Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

INTRODUCTION: Hepatitis C virus (HCV) is the second largest contributor to liver disease in the UK, with injecting drug use as the main risk factor among the estimated 200 000 people currently infected. Despite effective prevention interventions, chronic HCV prevalence remains around 40% among peopl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, Matthew, Dillon, John F, Elliott, Lawrie, De Angelis, Daniela, Vickerman, Peter, Foster, Graham, Donnan, Peter, Eriksen, Ann, Flowers, Paul, Goldberg, David, Hollingworth, William, Ijaz, Samreen, Liddell, David, Mandal, Sema, Martin, Natasha, Beer, Lewis J Z, Drysdale, Kate, Fraser, Hannah, Glass, Rachel, Graham, Lesley, Gunson, Rory N, Hamilton, Emma, Harris, Helen, Harris, Magdalena, Harris, Ross, Heinsbroek, Ellen, Hope, Vivian, Horwood, Jeremy, Inglis, Sarah Karen, Innes, Hamish, Lane, Athene, Meadows, Jade, McAuley, Andrew, Metcalfe, Chris, Migchelsen, Stephanie, Murray, Alex, Myring, Gareth, Palmateer, Norah E, Presanis, Anne, Radley, Andrew, Ramsay, Mary, Samartsidis, Pantelis, Simmons, Ruth, Sinka, Katy, Vojt, Gabriele, Ward, Zoe, Whiteley, David, Yeung, Alan, Hutchinson, Sharon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773339/
https://www.ncbi.nlm.nih.gov/pubmed/31551376
http://dx.doi.org/10.1136/bmjopen-2019-029538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773339/
https://www.ncbi.nlm.nih.gov/pubmed/31551376
http://dx.doi.org/10.1136/bmjopen-2019-029538

Ejemplares similares